Published in World J Gastroenterol on April 28, 2008
A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI). BMC Gastroenterol (2011) 0.96
Low expression of GNAI3 predicts poor prognosis in patients with HCC. Int J Clin Exp Med (2015) 0.75
Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet (1997) 10.05
Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology (1994) 9.86
Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis (2000) 6.05
National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002. Hepatology (2002) 5.16
Hepatocellular carcinoma and hepatitis C in the United States. Hepatology (2002) 3.00
Progression of fibrosis in chronic hepatitis C. Gastroenterology (2003) 2.77
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol (2000) 2.68
Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol (2002) 2.33
FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology (2007) 2.24
Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol (2002) 2.09
Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology (2000) 1.97
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology (2002) 1.94
Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res (2005) 1.59
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology (1998) 1.37
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat (1997) 1.29
Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology (1999) 1.14
Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough. J Viral Hepat (2002) 1.12
Estimated Prevalence of Viral Hepatitis in the General Population of the Municipality of São Paulo, Measured by a Serologic Survey of a Stratified, Randomized and Residence-Based Population. Braz J Infect Dis (1998) 1.04
Treatment of patients with hepatitis C and cirrhosis. Hepatology (2002) 1.02
Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. Acta Med Okayama (2006) 1.00
Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis (2000) 0.99
Steatosis and fibrosis in patients with chronic hepatitis C. J Clin Pathol (2004) 0.95
Evaluation of fibrosis and hepatitis C. Am J Med (1999) 0.91
Hepatitis C virus genotypes in Southern Brazil. Braz J Med Biol Res (1996) 0.88
Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. Eur J Gastroenterol Hepatol (2000) 0.88
Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C. J Viral Hepat (2001) 0.86
Diagnosis of hepatic fibrosis in patients with chronic hepatitis C. Clin Liver Dis (2006) 0.83
Factors associated with severity and disease progression in chronic hepatitis C. Hepatogastroenterology (1999) 0.83
Histopathology of chronic hepatitis C in relation to epidemiological factors. J Hepatol (1996) 0.83
Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence. J Viral Hepat (1998) 0.81
Liver iron accumulation in chronic hepatitis C patients without HFE mutations: relationships with histological damage, viral load and genotype and alpha-glutathione S-transferase levels. Eur J Gastroenterol Hepatol (2001) 0.81
Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C. J Hepatol (1999) 0.81
Interferon alpha in hepatitis C: a cytokine for reducing fibrosis progression. Eur Cytokine Netw (1997) 0.78
Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med (2009) 4.37
Long-term nutritional outcome after gastric bypass. Obes Surg (2009) 1.85
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Arch (2008) 1.71
Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study. Hepatology (2014) 1.60
Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma. J Clin Gastroenterol (2009) 1.56
Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? Liver Int (2010) 1.49
Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol (2007) 1.39
Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing. J Virol (2012) 1.29
Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat (2004) 1.16
Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol (2008) 1.02
Medicolegal liability in pathology: an international perspective. Semin Diagn Pathol (2007) 0.98
A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. J Hepatol (2008) 0.98
Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J Clin Endocrinol Metab (2010) 0.96
Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. Am J Transl Res (2012) 0.93
High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects. Nutrition (2008) 0.93
Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System. Am J Clin Oncol (2016) 0.92
Hepatic venous reconstruction in pediatric living-related donor liver transplantation--experience of a single center. Pediatr Transplant (2005) 0.92
Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis. Hepatology (2013) 0.90
Frequency of LCT -13910C>T single nucleotide polymorphism associated with adult-type hypolactasia/lactase persistence among Brazilians of different ethnic groups. Nutr J (2009) 0.89
Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment. J Am Coll Nutr (2008) 0.89
Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation (2003) 0.88
Characterization of hepatitis B virus (HBV) genotypes in patients from Rondônia, Brazil. Virol J (2010) 0.88
Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region. PLoS One (2010) 0.88
249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients. BMC Cancer (2009) 0.88
Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. J Nutr (2010) 0.88
Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. World J Gastroenterol (2006) 0.87
Nutritional profile of asymptomatic alcoholic patients. Arq Gastroenterol (2011) 0.86
Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer. Clin Endocrinol (Oxf) (2014) 0.86
Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings. Obes Surg (2005) 0.85
Frequency of concurrent autoimmune disorders in patients with autoimmune hepatitis: effect of age, gender, and genetic background. J Clin Gastroenterol (2008) 0.84
Phylogenetic analysis of hepatitis B virus genotype F complete genome sequences from Chilean patients with chronic infection. J Med Virol (2011) 0.84
Opportunity for catch-up HPV vaccination in young women after first delivery. J Epidemiol Community Health (2009) 0.84
Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil. Am J Gastroenterol (2003) 0.83
Association of LEC and tnpA Helicobacter pylori genes with gastric cancer in a Brazilian population. Infect Agent Cancer (2010) 0.83
Effect of the immunosuppressants on hepatocyte cells proliferation and apoptosis during liver regeneration after hepatectomy - molecular studies. Pediatr Transplant (2008) 0.83
Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and high plasma homocysteine in chronic hepatitis C (CHC) infected patients from the Northeast of Brazil. Nutr J (2011) 0.82
Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation. Pediatr Transplant (2006) 0.82
Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection. Antivir Ther (2014) 0.82
Searching for chronic hepatitis B patients in a low prevalence area--role of racial origin. BMC Fam Pract (2004) 0.82
Peritumoural, but not intratumoural, lymphatic vessel density and invasion correlate with colorectal carcinoma poor-outcome markers. Virchows Arch (2007) 0.81
Frequency and genotypic distribution of GB virus C (GBV-C) among Colombian population with Hepatitis B (HBV) or Hepatitis C (HCV) infection. Virol J (2011) 0.81
Phylogenetic analysis of complete genome sequences of hepatitis B virus from an Afro-Colombian community: presence of HBV F3/A1 recombinant strain. Virol J (2012) 0.80
Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma. Cancer Genet Cytogenet (2004) 0.80
Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications. Liver Int (2008) 0.79
Expression of interleukin 6 and apoptosis-related genes in suckling and weaning rat models of hepatectomy and liver regeneration. J Pediatr Surg (2007) 0.79
Fulminant encephalitis associated with a vaccine strain of rubella virus. J Clin Virol (2013) 0.79
Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil. BMC Public Health (2007) 0.79
Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. Obes Surg (2010) 0.79
Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Antivir Ther (2013) 0.79
Bone disease in primary biliary cirrhosis: lack of association with distal renal tubular acidosis. J Gastroenterol Hepatol (2005) 0.79
Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches. J Med Virol (2014) 0.79
Distribution and molecular characterization of hepatitis C virus (HCV) genotypes in patients with chronic infection from Pernambuco State, Brazil. Virus Res (2012) 0.79
Effect of the immunosuppressants on hepatocyte proliferation and apoptosis in a young animal model of liver regeneration: an immunohistochemical study using tissue microarrays. Pediatr Transplant (2008) 0.78
Distribution of hepatitis c virus (hcv) genotypes in patients with chronic infection from Rondônia, Brazil. Virol J (2011) 0.77
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Des Devel Ther (2013) 0.77
HBV carrying drug-resistance mutations in chronically infected treatment-naive patients. Antivir Ther (2015) 0.77
Distribution of hepatitis B virus (HBV) genotypes among patients with acute viral hepatitis. J Clin Gastroenterol (2005) 0.77
Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso-N-acetylcysteine in ob/ob mice. Biochem Pharmacol (2007) 0.77
p53 immunostaining pattern in Brazilian patients with hepatocellular carcinoma. Rev Inst Med Trop Sao Paulo (2004) 0.77
Clinical trials profile: professionals and sites. Contemp Clin Trials (2010) 0.76
Detection of Hepatitis B virus subgenotype A1 in a Quilombo community from Maranhão, Brazil. Virol J (2011) 0.76
Surgical margin size in hepatic resections for colorectal metastasis: impact on recurrence and survival. Arq Bras Cir Dig (2014) 0.75
Distribution of hepatitis B virus subgenotype F2a in São Paulo, Brazil. BMC Res Notes (2013) 0.75
Micronuclei formation in liver fibrosis samples from patients infected by hepatitis C virus. Genet Mol Biol (2010) 0.75
Is hepatic venous pressure gradient assessment required before liver resection in patients with cirrhosis and hepatocellular carcinoma? Clinics (Sao Paulo) (2013) 0.75
A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis. J Hepatol (2004) 0.75
Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease. Menopause (2016) 0.75